Ethyl acetate fraction of adlay bran ethanolic extract inhibits oncogene expression and suppresses DMH-induced preneoplastic lesions of the colon in F344 rats through an anti-inflammatory pathway

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 13, 2010, Pages 7616-7623

  Chung, Cheng Pei ^a   Hsu, Hsin Yi ^b   Huang, Din Wen ^a   Hsu, Hsing Hua ^a   Lin, Ju Tsui ^a   Shih, Chun Kuang ^c   Chiang, Wenchang ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b ALETHEIA UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adlay bran; Cyclooxygenase 2 (cox 2); Mucin depleted foci (mdf); RAS; Wee1

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ACETIC ACID DERIVATIVE; ACETIC ACID ETHYL ESTER; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; ETS2 PROTEIN, RAT; ONCOPROTEIN; PLANT EXTRACT; PROTEIN P21; TRANSCRIPTION FACTOR ETS 2;

ANIMAL; ARTICLE; CHEMISTRY; COIX; COLON TUMOR; DISEASE MODEL; DOWN REGULATION; DRUG EFFECT; FISCHER 344 RAT; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; MALE; PATHOLOGY; RAT; COLONIC NEOPLASMS; DRUG EFFECTS;

1,2-DIMETHYLHYDRAZINE; ACETATES; ANIMALS; ANTI-INFLAMMATORY AGENTS; COIX; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION; HUMANS; MALE; ONCOGENE PROTEIN P21(RAS); PLANT EXTRACTS; PROTO-ONCOGENE PROTEIN C-ETS-2; PROTO-ONCOGENE PROTEINS; RATS; RATS, INBRED F344;

ANIMALIA; COIX; COIX LACRYMA-JOBI; RATTUS;

EID: 77954554246     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf101084e     Document Type: Article

References (30)

1. Potter, J. D. Risk factors for colon neoplasia. Epidemiology and, biology. Eur. J. Cancer 1996, 31 A, 1033-1038.
2. Slattery, M. L.; Edwards, S. L.; Boucher, K. M.; Anderson, K.; Caan, B. J. Lifestyle and colon cancer: an assessment of factors associated with risk. Am. J. Epidemiol. 1999, 150, 869-877.
3. Corpet, D. E.; Tache, S. Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci, and tumor data, ranked by potency. Nutr. Cancer 2002, 43, 1-21.
4. Jenab, M.; Chen, J. M.; Thompson, L. U. Sialomucin production in aberrant crypt foci relates to degree of dysplasia and rate of cell proliferation. Cancer Lett. 2001, 165, 19-25.
5. Femia, A. P.; Dolara, P.; Giannini, A.; Salvadori, M.; Biggeri, A.; Caderni, G. Frequent mutation of APC gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis. Cancer Res. 2007, 67, 445-449.
6. Singer, I. I.; Kawka, D. W.; Schloemann, S.; Tessner, T.; Riehl, T.; Stenson, W. F. Cyclooxygenase 2 is induced, in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 1998, 115, 297-306.
7. Ohta, T.; Takahashi, M.; Ochiaic, A. Increased protein expression of both inducible nitric oxide synthase and cyclooxygenase-2 in human colon cancers. Cancer Lett. 2005, 239, 246-253.
8. Reddy, B. S.; Rao, C. V.; Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for the potential chemopreventive properties in colon carcinogenesis. Cancer Res. 1996, 56, 4566-4569.
9. Shih, C. K.; Chiang, W. C; Kuo, M. L. Effects of adlay on azoxymethane-induced colon carcinogenesis in rats. Food Chem. Toxicol. 2004, 42, 1339-1347.
10. Lee, M. Y.; Tsai, S. IL; Kuo, Y. H.; Chiang, W. Anti-tumor and antiinflammatory activity of the methanol extracts from adlay bran. Food Sci. Biotechnol. 2008, 17, 1265-1271.
11. 2+-treated low-density lipoprotein (LDL) oxidation and lipopolysaccharide (LPS)-induced inflammation in RAW 264.7 macrophage. J., Agric. Food Chem. 2009, 57, 2259-2266.
12. Reeves, P. G. Components of AIN-93 diets as improvements in the AIN-76A diet. J. Nutr. 1997, 127, 838S-841S.
13. Calaluce, R.; Earnest, D. L.; Heddens, D.; Einspahr, J. G.; Roe, D.; Bogert, C. L.; Marshall, J. R.; Alberts, D. S. Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial. Cancer Epidemiol. Biomarkers Prev. 2000, 9, 1287-1292.
14. Bird, R. P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 87, 37, 147-151.
15. Caderni, G.; Femia, A. P.; Giannini, A.; Favuzza, A.; Luceri, C.; Salvadori, M.; Dolara, P. Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res. 2003, 63, 2388-2392.
16. Chomczynski, P.; Sacchi, N. Single step method of RNA isolation by acid guanidium-thiocyanate-phenol-chloroform extraction. Anal. Binchem. 1987, 162, 156-159.
17. Kameue, C.; Tsukahara, T.; Ushida, K. Alteration of gene expression in the colon of colorectal cancer model rat by dietary sodium gluconate. Biosci. Biotechnol. Biochem. 2006, 70, 606-614.
18. Caderni, G.; Giannini, A.; Lancioni, L.; Luceri, C.; Biggeri, A.; Dolara, P. Characterization of aberrant crypt foci, in carcinogentreated rats: association with intestinal, carcinogenesis. Br. J. Cancer 1995, 71, 763-769.
19. Green, J. E.; Hudson, T. The promise of genetically engineered mice for cancer prevention studies. Nat. Rev. Cancer 2005, 5, 184-198.
20. Calcagno, S. R.; Li, S.; Colon, M.; Kreinest, P. A.; Thompson, E. A.; Fields, A. P.; Murray, N. R. Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon. Int. J. Cancer 2008, 122, 2462-2470.
21. Stope, M. B.; Vom Doip, F.; Szatkowski, D.; Böhm, A.; Keiper, M.; Noite, J.; Oude Weernink, P. A.; Rosskopf, D.; Evellin, S.; Jakobs, K. H.; Schmidt, M. Rap2B-dependent stimulation of phospholipase C-epsilon by epidermal, growth factor receptor mediated by c-Src phosphorylation of RasGRP3. Mol. Cell. Biol. 2004, 24, 4664-4676.
22. Lee, S. M.; Li, M. L.; Tse, Y. C.; Leung, S. C.; Lee, M. M.; Tsui, S. K.; Fung, K. P.; Lee, C. Y.; Waye, M. M. Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway. Life Sci. 2002, 71, 2267-2277.
23. Kannangai, R.; Vicekanandan, P.; Martinez-Murillo, F.; Choti, M.; Torbenson, M. Fibrolamellar carcinomas shows overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways. Hum. Pathol. 2007, 38, 639-644.
24. Kato, T.; Daigo, Y.; Hayama, S.; Ishikawa, N.; Yamabuki, T.; Ito, T.; Miyamoto, M.; Kondo, S.; Nakamura, Y. A novel human tRNA-dihydrouridine synthase involved in pulmonary carcinogenesis. Cancer Res. 2005, 65, 5638-5646.
25. Boutros, R.; Lobjois, V.; Ducommun, B. CDC25 phosphatases in cancer cells: key players? Good, targets? Nat. Rev. Cancer. 2007, 7, 495-507.
26. Kawabata, K.; Yamamoto, T.; Hara, A.; Shimizu, M.; Yamada, Y.; Matsunaga, K.; Tanaka, T.; Mori, H. Modifying effects of ferulic acid on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Lett. 2000, 157, 15-21.
27. Han, B. S.; Park, C. B.; Takasuka, N.; Naito, A.; Sekine, K.; Nomura, E.; Taniguchi, H.; Tsuno, T.; Tsuda, H. A ferulic acid derivative, ethyl 3-(4′-geranyloxy-3-methoxyphenyl)-2-propenoate, as a new candidate chemopreventive agent for colon carcinogenesis in the rat. Jpn. J. Cancer Res. 2001, 92, 404-409.
28. Wargovich, M. J.; Jimenez, A.; McKee, K. E.; Steele, V.; Velasco, M.; Woods, J.; Price, R.; Gray, K. J.; Kelloff, G. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinoeenesis 2000, 21, 1149-1155.
29. Lee, M. Y.; Lin, H. Y.; Cheng, F.; Chiang, W. C.; Kuo, Y. H. Isolation and, characterization of new lactam compounds that inhibit lung and, colon cancer cells from adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) bran. Food Chem. Toxicol. 2008, 46, 1933-1999.
30. 2/M arrest, and regulation of gene expression. J. Gastroenterol. Hepatol. 2005, 20, 1046-1053.